Genomic Malpractice: An Emerging Tide or Gentle Ripple? (Open Access)
Food and Drug Law Journal | Volume 73 | Number 1
Step Therapy: Legal, Ethical, and Policy Implications of a Cost-Cutting Measure
Food and Drug Law Journal | Volume 73 | Number 1
Recommendations for Regulating Software-Based Medical Treatments: Learning from Therapies for Psychiatric Conditions GalleryRecommendations for Regulating Software-Based Medical Treatments: Learning from Therapies for Psychiatric Conditions
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1
Recommendations for Regulating Software-Based Medical Treatments: Learning from Therapies for Psychiatric Conditions
Food and Drug Law Journal | Volume 73 | Number 1
- Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men Gallery
Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1
Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men
Food and Drug Law Journal | Volume 73 | Number 1
- Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power? Gallery
Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1
Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?
Food and Drug Law Journal | Volume 73 | Number 1
Changing Our Minds: Reforming the FDA Medical Device Reclassification Process
Food and Drug Law Journal | Volume 73 | Number 1
New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures GalleryNew Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures
Archived Event, Drugs, Medical Devices, Biologics, Event, Medical Products Webinars, On-demand Webinar, Webinars Homepage
New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures
Recorded February 9, 2018 | On-Demand Webinar
The FDA Reauthorization Act and GDUFA II: What You Need to Know
Rescheduled. Date To Be Announced Shortly
DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age GalleryDEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age
Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update November/December 2017
DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age
Update Magazine | November/December 2017
Real World Evidence: Data Requirements, Utilization, and Presentation
Recorded December 1, 2017 | On-Demand Webinar
